Zacks Investment Research cut shares of Linde Ag Spon (NASDAQ:LNEGY) from a buy rating to a hold rating in a research report report published on Saturday.

According to Zacks, “The Linde Group is an engineering company which supplies industrial, process and specialty gases worldwide. The Company’s core operating segments consist of the gases and engineering division. The main gases produced by the Company are acetylene, carbon dioxide, nitrogen, hydrogen, shielding gases for welding applications, noble gases, calibration gas mixtures, high-purity gases and gas mixtures. It also supplies welding and safety products. Lindes’s pharmaceutical and medical gas products and services find their use in clinical care, emergency care, and ventilation therapy and hospital infrastructure. The engineering division focuses on plant engineering for the production of hydrogen and synthesis gas, oxygen and olefins as well as plants for natural gas treatment. The Company’s non core division the gist division operates in a wide range of commercial and industrial sectors including grocery, retail, electronics and gas. . The Linde Group is headquartered in Munich, Germany. “

Separately, HSBC Holdings plc upgraded shares of Linde Ag Spon from a hold rating to a buy rating in a report on Thursday, May 4th. One research analyst has rated the stock with a sell rating, two have issued a hold rating and two have given a buy rating to the stock. Linde Ag Spon currently has an average rating of Hold and a consensus target price of $22.00.

Shares of Linde Ag Spon (NASDAQ:LNEGY) opened at 19.22 on Friday. The company’s 50-day moving average price is $19.37 and its 200 day moving average price is $18.13. Linde Ag Spon has a one year low of $15.35 and a one year high of $20.16. The stock has a market capitalization of $35.68 billion and a PE ratio of 27.04.

ILLEGAL ACTIVITY WARNING: This piece of content was originally posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this piece of content on another domain, it was illegally copied and republished in violation of U.S. and international trademark & copyright law. The legal version of this piece of content can be viewed at

Get a free copy of the Zacks research report on Linde Ag Spon (LNEGY)

For more information about research offerings from Zacks Investment Research, visit

Receive News & Stock Ratings for Linde Ag Spon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Linde Ag Spon and related stocks with our FREE daily email newsletter.